Drug Type siRNA |
Synonyms- |
Target |
Action stimulants |
Mechanism PLG stimulants(Plasminogen stimulants), RNAi(RNA interference) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Preclinical | Global | 01 Jun 2026 | |
| Hemophilia B | Preclinical | Global | 01 Jun 2026 | |
| Telangiectasia, Hereditary Hemorrhagic | Preclinical | Global | 01 Jun 2026 |





